<p>Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China</p>Wanren Peng, Guoping Sun, Fenglin Zhang et al.|Cancer Management and Research|2020Cited by 39
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYing–Hong Shi, Enxiao Li, Weidong Jia et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 39